Cargando…
Serum Amyloid P Component Ameliorates Neurological Damage Caused by Expressing a Lysozyme Variant in the Central Nervous System of Drosophila melanogaster
Lysozyme amyloidosis is a hereditary disease in which mutations in the gene coding for lysozyme leads to misfolding and consequently accumulation of amyloid material. To improve understanding of the processes involved we expressed human wild type (WT) lysozyme and the disease-associated variant F57I...
Autores principales: | Helmfors, Linda, Bergkvist, Liza, Brorsson, Ann-Christin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948765/ https://www.ncbi.nlm.nih.gov/pubmed/27428539 http://dx.doi.org/10.1371/journal.pone.0159294 |
Ejemplares similares
-
Beneficial effects of increased lysozyme levels in Alzheimer's disease modelled in Drosophila melanogaster
por: Sandin, Linnea, et al.
Publicado: (2016) -
Serum amyloid P component promotes formation of distinct aggregated lysozyme morphologies and reduces toxicity in Drosophila flies expressing F57I lysozyme
por: Bergkvist, Liza, et al.
Publicado: (2020) -
Exploring Aβ Proteotoxicity and Therapeutic Candidates Using Drosophila melanogaster
por: Elovsson, Greta, et al.
Publicado: (2021) -
Disease-related amyloidogenic variants of human lysozyme trigger the unfolded protein response and disturb eye development in Drosophila melanogaster
por: Kumita, Janet R., et al.
Publicado: (2012) -
AβPP processing results in greater toxicity per amount of Aβ(1-42) than individually expressed and secreted Aβ(1-42) in Drosophila melanogaster
por: Bergkvist, Liza, et al.
Publicado: (2016)